Aim: study of patients with atrial fibrillation (AF) needs in terms of therapy monitoring using a mobile application (MА) and the development of the required functions of the MА.
Materials and methods: 96 patients, 18 years of age and older (mean age 57,3±11,9) with a diagnosis of AF receiving anticoagulant therapy were included. We developed a questionnaire to assess the needs of patients with AF in terms of the use of MA, which included questions regarding the readiness of patients to use the developed MA in everyday life, their expectations regarding its interface and functionality.
Results: To study the expectations, needs for certain functions, as well as fears when working with MA, 96 patients (100%) were surveyed. Based on the results of the survey, the main expectations from the developed product were identified as follows: communication with a doctor to control therapy — 96% of respondents (n = 92), improved adherence to therapy — 94% of respondents (n=90). The most common fear was an incomprehensible interface — 21% of respondents (n = 20). Mean age of patients «ready to use MA» was 54,2±12,2 vs. 60,3±10,3 in the group «not ready to use MA» (p = 0,01). Prompt communication with the doctor was considered as the most important function in MA (45 (47%)).
Conclusion: A study of the needs of patients with AF in terms of the developed MA showed that the most important parameters were the convenience and ease of use, and the most demanded function of the MA was the possibility of prompt communication with the doctor.
Materials and methods: 96 patients, 18 years of age and older (mean age 57,3±11,9) with a diagnosis of AF receiving anticoagulant therapy were included. We developed a questionnaire to assess the needs of patients with AF in terms of the use of MA, which included questions regarding the readiness of patients to use the developed MA in everyday life, their expectations regarding its interface and functionality.
Results: To study the expectations, needs for certain functions, as well as fears when working with MA, 96 patients (100%) were surveyed. Based on the results of the survey, the main expectations from the developed product were identified as follows: communication with a doctor to control therapy — 96% of respondents (n = 92), improved adherence to therapy — 94% of respondents (n=90). The most common fear was an incomprehensible interface — 21% of respondents (n = 20). Mean age of patients «ready to use MA» was 54,2±12,2 vs. 60,3±10,3 in the group «not ready to use MA» (p = 0,01). Prompt communication with the doctor was considered as the most important function in MA (45 (47%)).
Conclusion: A study of the needs of patients with AF in terms of the developed MA showed that the most important parameters were the convenience and ease of use, and the most demanded function of the MA was the possibility of prompt communication with the doctor.